Background. Tumor necrosis factor (TNF)-␣ is a cytokine with pleiotropic effects on the liver. The predominant hepatic receptor for TNF␣ is TNF receptor-1 (TNFR1). TNFR1 mediates liver injury after ischemia/reperfusion but is also mitogenic during hepatic regeneration. This study investigated the role of graft and host TNFR1 in early graft injury after liver transplantation in mice. Methods. Livers from TNFR1 deficient (TNFR1Ϫ/Ϫ) and wild type (WT) mice were transplanted into either TNFR1Ϫ/Ϫ or WT recipients in all four possible combinations after 12 hours of cold storage. After eight hours, alanine transferase (ALT), necrosis, TdT-mediated dUTP-digoxigenin nick-end labeling (TUNEL) staining, caspase-3 activation, and myeloperoxidase were determined. Results. When TNFR1Ϫ/Ϫ livers were transplanted into either WT or TNFR1Ϫ/Ϫ recipients, ALT was twofold greater than when WT donor livers were used. Necrosis and TUNEL staining also increased twofold and sevenfold, respectively, after transplantation of TNFR1Ϫ/Ϫ donor livers compared to WT. By contrast, ALT and necrosis decreased when WT or TNFR1Ϫ/Ϫ livers were transplanted into TNFR1Ϫ/Ϫ hosts compared to WT, which was associated with decreased neutrophil infiltration. Conclusion. In conclusion, graft and recipient TNFR1 has opposing effects. Graft TNFR1 decreases graft injury, whereas recipient TNFR1 mediates an increase of injury associated with enhanced neutrophil infiltration. Cross-transplanting of knockout and wild-type livers provides a new means to investigate graft-host interactions during hepatic injury.
O rthotopic liver transplantation (OLT) is a life-saving therapy for irreversible liver disease whose application is limited by a shortage of suitable donor livers (1) . Cold storage/ reperfusion injury as a consequence of liver preservation can result in extensive hepatic necrosis, poor initial graft function and primary graft failure. Transplanted livers react to necrosis by initiating a proliferative hepatocellular response within hours of surgery, which serves to regenerate hepatocytes and repair liver damage from preservation injury (2) .
Tumor necrosis factor (TNF)-␣ plays an important role in early graft injury (3, 4) and in hepatic regeneration (5) . After warm hepatic ischemia/reperfusion, hepatic injury due to an apparent apoptotic pathway is decreased in TNF␣ receptor-1 (TNFR1) knockout (Ϫ/Ϫ) mice (6) . By contrast, TNFR1 receptors are essential in liver regeneration after partial hepatectomy (7) . Whether TNFR1 receptors contribute to liver damage after transplantation is not known.
Accordingly, the aim of this study was to determine the specific roles of donor and host TNFR1 receptors in posttransplant injury by transplanting livers from TNFR1Ϫ/Ϫ and wild-type (WT) mice into TNFR1Ϫ/Ϫ and WT mice in all possible combinations. Using this approach, we demonstrate that donor liver TNFR1 receptors blunt hepatocellular injury, whereas host recipient TNFR1 receptors aggravate liver damage and promote neutrophil infiltration.
MATERIALS AND METHODS

Experimental Animals and Surgical Procedures
Inbred eight-to 10-week-old male TNFR1Ϫ/Ϫ mice on a C57Bl/6 background and corresponding wild-type (WT) C57Bl/6 mice (Jackson Laboratory, Bar Harbor, ME) were allowed free access to laboratory chow and water. Orthotopic mouse liver transplantation was performed under anesthesia using methoxyflurane (Schering-Plough, NJ), as previously described (8, 9) . Briefly, explanted donor livers were prepared with cuffs on the infrahepatic vena cava and portal vein. Explants were then stored in ice-cold University of Wisconsin (UW) solution for 12 hours. After storage, the explants were rinsed with 4 mL of lactated Ringer's solution at room temperature and implanted into recipients by anastomosing the suprahepatic vena cava with a running 10 -0 nylon suture (Ethicon Inc. Somerville, NJ) and connecting the cuffs to the corresponding recipient vessels. Anhepatic time averaged 19 min. Estimated blood loss was less than 0.2 mL, which was replaced with lactated Ringer's solution. The bile duct was anastomosed over a polyethylene PE10 intraluminal stent. The abdominal wall was then closed in two layers with 7-0 Prolene (Ethicon Inc.).
TNFR1Ϫ/Ϫ and WT mice were transplanted in all four possible combinations: WT to WT, TNFR1Ϫ/Ϫ to TNFR1Ϫ/Ϫ, WT to TNFR1Ϫ/Ϫ, and TNFR1Ϫ/Ϫ to WT. Additionally, a group of TNFR1Ϫ/Ϫ and WT mice underwent sham operations (anesthesia and laparotomy) to serve as controls. After transplantation, recipient mice had free access to chow and water. All animals were given human care using protocols approved by the Institutional Animal Care and Use Committee of the University of North Carolina.
Enzyme Assay
Heparinized blood samples were collected eight hours after transplantation by puncture of the inferior vena cava during euthanasia under methoxyflurane anesthesia. Serum was obtained by centrifugation and stored at Ϫ80°C until analysis. Alanine aminotransferase (ALT) activity was determined using a commercial kit (Sigma Diagnostics).
Histological Procedures
Livers of anesthetized mice were flushed with lactated Ringer's solution and fixed by immersion in 10% buffered formalin, embedded in paraffin, and processed for histology. Tissue damage was assessed in hematoxylin and eosin-stained sections by estimating the proportion of necrotic areas in 10 random fields at 100ϫ magnification by image analysis (MetaMorph, Universal Imaging Corporation). One observer blinded to treatment groups performed the histologic evaluations.
In Situ TdT-mediated dUTP-digoxigenin Nick-end Labeling (TUNEL) Staining
At eight hours after transplantation, livers were harvested and fixed in 10% buffered formalin. Paraffin-embedded sections were stained by the TUNEL method, using an in situ cell death detection kit (Roche Molecular Biochemicals, Mannheim, Germany), as described (10) . After deparaffinization, the sections were incubated with proteinase K (Roche) at 20 g/ml for 20 min at 37°C, and endogenous peroxidase activity was quenched with 3% hydrogen peroxide. The sections were then rinsed with phosphate-buffered saline (PBS) and incubated with 50 l of terminal deoxynucleotidyl transferase (TdT) buffer in a moist chamber at 37°C for 60 minutes. Incorporated fluorescein was detected by fluorescence microscopy. Positive and negative controls consisted of test sections pretreated with DNAse I and sections stained without deoxynucleotide substrate, respectively. For each specimen, cells with positive nuclei were counted in five pericentral and five periportal microscopic fields (ϫ200). Data values were expressed as the average number of TUNEL-positive cells per high power field. Data of the periportal fields are not shown because less than one TUNEL positive cell/periportal field was detected in all tissues.
Activated Caspase-3 Immunohistochemistry
Liver sections were deparaffinized, rehydrated, and stained immunohistochemically with a polyclonal antibody (R&D Systems) specific for activated caspase-3. Peroxidase-linked secondary antibody and diaminobenzidine were used to detect specific binding, and sections were counterstained with hematoxylin.
Myeloperoxidase Immunohistochemistry
Liver sections were prepared for immunohistochemistry as described above, and a polyclonal rabbit antihuman myeloperoxidase (MPO) antibody (DAKO) in PBS (pHϭ7.4) containing 1% Tween 20 and 1% bovine serum albumin was applied. Peroxidase-linked secondary antibody and diaminobenzidine were used to detect specific binding, and sections were counterstained with hematoxylin. No positive staining was detected when tissue was processed without primary antibody, indicating that nonspecific binding did not occur under these conditions. Light microscopy was used to quantify the percentage of MPO-positive cells by measuring 45 randomly selected fields per slide at a 400ϫ magnification. The observer was blinded to study groups for evaluation.
Statistics
Mean valuesϮstandard error of the mean for groups were compared using two-way analysis of variance (ANOVA) with Student-Newman-Keuls posthoc test as appropriate. Multivariate analysis combined two groups to detect differences in "donor" or "recipient" groups. PϽ0.05 was used as the criterion for significance. Two-tailed tests were used except when assessing a unidirectional hypothesis. FIGURE 1. Serum ALT after liver transplantation using WT and TNFR1Ϫ/Ϫ donor and recipient mice. Serum ALT was measured eight hours after transplantation of WT and TNFR1Ϫ/Ϫ donor liver grafts into WT and TNFR1Ϫ/Ϫ recipients in all four combinations (nϭ6, per group). ALT release was greater in TNFR1Ϫ/Ϫ donor livers and lower in TNFR1Ϫ/Ϫ recipients by two-way analysis of variance (PϽ0.05).
RESULTS
Increased ALT Release after Transplantations of TNFR1؊/؊ Donor Liver Grafts into WT Recipient Hosts
Orthotopic mouse liver transplantation was performed between WT and TNFR1Ϫ/Ϫ mice in all possible combinations: WT to WT, TNFR1Ϫ/Ϫ to TNFR1Ϫ/Ϫ, WT to TNFR1Ϫ/Ϫ, and TNFR1Ϫ/Ϫ to WT. The four combinations were comparable in terms of anhepatic time and body weight of recipients (data not shown). ALT as an indicator of hepatic injury was evaluated at eight hours after transplantation or sham operation. After sham operation, ALT averaged 45Ϯ5 U/L in both WT and TNFR1Ϫ/Ϫ mice (data not shown). After transplantation, ALT increased at least 75-fold in all groups. Two-way ANOVA revealed that ALT was significantly greater (1.7-fold; Pϭ0.018) when donor grafts were from TNFR1Ϫ/Ϫ mice rather than WT mice (Fig. 1) . By contrast, ALT was significantly less (1.8-fold; Pϭ0.012) when recipient hosts were TNFR1Ϫ/Ϫ mice instead of WT mice (Fig. 1) . These results suggest that TNFR1 in the donor graft protects against injury, whereas TNFR1 in the recipient host promotes injury.
Increased Histopathological Injury in Transplantations Involving TNFR1؊/؊ Donor Grafts and WT Recipient Hosts
In hematoxylin and eosin-stained sections, no pathological changes were observed in livers of sham-operated mice (data not shown). By contrast, transplanted livers exhibited pericentral and midlobular necrosis and infiltration of leukocytes at eight hours after surgery (Fig. 2) . Necrotic areas increased after transplantation of TNFR1Ϫ/Ϫ livers into WT recipient hosts (Fig. 2C) compared to WT to WT transplantation ( Fig. 2A) . By contrast, necrosis decreased in WT to TNFR1Ϫ/Ϫ transplantation (Fig. 2B) . Little difference in necrosis was observed between TNFR1Ϫ/Ϫ to TNFR1Ϫ/Ϫ transplantation ( Fig. 2A and D) and WT to WT transplantation ( Fig. 2A) . Similar to findings with ALT, two-way ANOVA revealed that hepatic necrosis was greater when TNFR1Ϫ/Ϫ mice provided donor grafts than when WT mice were donors (42.9% necrotic area vs. 23.1%; Pϭ0.019, Figure  2E ). By contrast, necrosis was smaller when TNFR1Ϫ/Ϫ mice were graft recipients compared to WT recipients (20.2% necrotic area vs. 45.8%; Pϭ0.004, Fig. 2E ).
Increased TUNEL Staining and Caspase-3 Activation in TNFR1؊/؊ Donor Liver Grafts
To detect DNA strand breaks in liver samples, TUNEL staining was performed (Fig. 3) . In WT to WT transplantation, some TUNEL staining was observed in pericentral regions (Fig. 3A) . TUNEL staining increased markedly after TNFR1Ϫ/Ϫ to WT transplantation (Fig. 3C ), but little difference was observed after WT to TNFR1Ϫ/Ϫ and TNFR1Ϫ/Ϫ to TNFR1Ϫ/Ϫ transplantation ( Fig. 3B and D) . Two-way ANOVA revealed that TUNEL staining was 6.7-fold increased after transplantation of TNFR1Ϫ/Ϫ donor livers compared to WT donor livers (16.7 TUNEL positive nuclei per pericentral area vs. 2.5; Pϭ0.027, Fig. 3E ). No significant difference of TUNEL staining was observed between TNFR1Ϫ/Ϫ recipient hosts and WT recipient hosts (PϾ0.1).
Immunohistochemistry for activated caspase-3 was also used as a marker of apoptosis after transplantation (Fig.   4) . After WT to WT transplantation, scattered immunoreactivity for activated caspase-3 was observed in pericentral and midzonal regions (Fig. 4A) . After TNFR1Ϫ/Ϫ to WT transplantation, caspase-3 activation markedly increased (Fig.  4C ). Caspase-3 activation occurred to a lesser extent after WT to TNFR1Ϫ/Ϫ transplantation and TNFR1Ϫ/Ϫ to TNFR1Ϫ/Ϫ transplantation ( Fig. 4B and D) , compared to TNFR1Ϫ/Ϫ to WT transplantation but was greater compared to WT to WT transplantation. Together, the results for TUNEL and activated caspase indicated that apoptosis was less when donor grafts contained TNFR1.
Neutrophil Infiltration into Transplanted Livers
Neutrophil infiltration promoted by TNF␣ is implicated in hepatic ischemia/reperfusion and storage reperfusion injury (11) . To test the hypothesis that neutrophil infiltration is greater in WT than TNR1Ϫ/Ϫ recipient mice after liver transplantation, liver sections were stained for MPO, a marker for neutrophils. In livers of sham-operated WT and TNFR1Ϫ/Ϫ mice, the number of MPO positive cells per high-power field (HPF) was 0.95Ϯ0.09 (nϭ4) and 0.98Ϯ0.32 (nϭ3), respectively. After liver transplantation, 
DISCUSSION
TNF␣ is a pleiotropic cytokine that exerts a variety of effects on liver. Numerous studies suggest that TNF␣ is involved in the pathogenesis of hepatic ischemia and reperfusion injury (4, (12) (13) (14) (15) . Other studies report aggravating effects of TNF␣ and lipopolysaccharide on hepatic injury after rat liver transplantation (4, 16) . Of the two receptor isoforms, TNFR1 (p55) and TNFR2 (p75), most biological activities seem mediated by TNFR1 to which TNF␣ also has the highest binding affinity (17, 18) . TNFR1 is highly expressed in hepatocytes and Kupffer cells and mediates a wide range of biological responses, including inflammation, tumor necrosis, cell proliferation, differentiation, and apoptosis. TNFR1 is responsible for most proinflammatory effects of TNF␣ (19 -21) . After warm ischemia/reperfusion, hepatic injury was decreased in TNFR1 deficient mice due to an apparent inhibition of apoptosis induced by TNF␣ (6). TNFR1-dependent signaling also leads to activation of NF-kB, which induces expression of a variety of antiapoptotic proteins that protect against TNF␣-induced apoptosis (14, 22, 23) . In addition, TNFR1 receptors play a key role in the proliferative response in liver regeneration after partial hepatectomy (7) . Accordingly, this study was conducted to investigate the possible adverse and beneficial roles of graft and host TNFR1 in liver transplantation. We applied a technique of "cross-transplantation" to determine the specific effects of TNFR1 deficiency in either donor grafts or recipient hosts. By performing transplantations with WT and TNFR1 deficient donors and recipients in all four possible combinations, we showed that donor TNFR1 protects against graft injury whereas recipient TNFR1 promotes injury.
When TNFR1Ϫ/Ϫ donor livers were transplanted into either WT or TNFR1Ϫ/Ϫ recipient hosts, hepatocellular damage increased compared to when WT donor livers were transplanted. Increased injury was manifested by greater ALT release, necrosis, TUNEL, and caspase-3 activation (Figs.  1-4) . Previously after 75 min of warm ischemia and three hours of reperfusion, apoptosis assessed by TUNEL in TNFR1Ϫ/Ϫ mice was decreased from 82% to 18% compared to WT mice, suggesting that TNFR1 receptors mediate hepatocellular damage after warm ischemia via an apoptotic pathway (6) . By contrast after cold storage and transplantation, we observed more TUNEL staining in TNFR1Ϫ/Ϫ donor grafts than in WT donor grafts. This difference may be due to the opposing effect of intrahepatic (donor) and extrahepatic (recipient) TNFR1. Differences in the extent of apoptosis may also reflect the different models used (warm ischemia/reperfusion vs. cold storage/transplantation) and the different observation time points (3 hours vs. 8 hours). TUNEL after ischemia/reperfusion can also reflect DNA degradation in necrotic nuclei (24) . In the present study, TUNEL was accompanied caspase-3 activation. Thus, our findings showed that TNFR1 deficiency in donor livers increased both apoptosis and necrosis, whose occurrences together constitute necrapoptosis (25) . Taken together, these findings show that TNFR1 in the graft, likely on hepatocytes, is protective after liver transplantation.
By contrast, graft injury decreased when WT and TNFR1Ϫ/Ϫ donor livers were transplanted into TNFR1Ϫ/Ϫ host recipients compared to WT recipients. Decreased graft injury was manifested by decreased ALT release, necrosis, and TUNEL staining (Figs. 1-3 ). Decreased liver injury was also associated with decreased neutrophil infiltration in the graft (Fig. 5) . Taken together, these findings indicate that host TNFR1 promotes liver graft injury. A likely mechanism is TNFR1-dependent infiltration of polymorphonuclear neutrophils (PMNs) and other leukocytes into the hepatic parenchyma (Fig. 6 ). TNFR1 is a membrane receptor not only on hepatocytes and macrophages but also on PMNs (26). Although parenchymal cell apoptosis per se does not recruit PMNs into the liver, if PMNs are activated, then apoptosis can trigger PMN transmigration and injury (27) . In the lung, PMN activation and infiltration strongly depend on TNFR1, and TNFR1 facilitates pulmonary PMN infiltration after inhalation of lipopolysaccharide (28) . Because PMN infiltration contributes to the late phase of ischemia/reperfusion injury to liver in vivo (11) , suppression of TNF␣-dependent PMN infiltration after transplantation of liver grafts into TNFR1Ϫ/Ϫ mice may account in part for decreased graft injury. In agreement with earlier studies in which TNFR1 deficiency did not change the content of inflammatory cells in the liver (29) , PMN content of sham-operated WT and TNFR1Ϫ/Ϫ livers was nearly identical. Similarly, graft PMN content after transplantation was not statistically different between WT and TNFR1 Ϫ/Ϫ donors. Because hepatic PMNs increased after transplantation, the origin of increased graft PMNs must have been from the host. Moreover, PMNs stained normally for MPO in sham-operated TNFRϪ/Ϫ livers. Thus, decreased PMN counts in TNFRϪ/Ϫ host recipients cannot be attributed to MPO deficiency.
Neither increased nor decreased liver damage occurred when TNFR1Ϫ/Ϫ liver grafts were implanted into TNFR1Ϫ/Ϫ recipient hosts compared with WT to WT transplantation (Figs. 1-3 ). This lack of effect seems to represent compensation of the protective and aggravating effects of graft and recipient TNFR1. In conclusion, cross transplantations using knockout mice revealed pleiotropic effects of TNFR1 on graft injury after liver transplantation depending on whether TNFR1 resides in the donor graft or the recipient host (Fig. 6 ). Donor liver TNFR1 protects against hepatocellular damage, whereas recipient host TNFR1 promotes possible neutrophil-dependent liver injury.
